TMPRSS2: Potential Biomarker for COVID-19 Outcomes.
作者： Jonathan D. Strope , Cindy H. Chau, PharmD , William D. Figg
DOI: 10.1002/JCPH.1641
关键词: Virology 、 Coronavirus disease 2019 (COVID-19) 、 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 、 Betacoronavirus 、 TMPRSS2 、 Coronavirus 、 2019-20 coronavirus outbreak 、 Biomarker (medicine) 、 Potential biomarkers 、 Medicine
摘要:
sci-hub.st 参考文章(26)
Veda N. Giri, Karen Ruth, Lucinda Hughes, Robert G. Uzzo, David Y.T. Chen, Stephen A. Boorjian, Rosalia Viterbo, Timothy R. Rebbeck, Racial differences in prediction of time to prostate cancer diagnosis in a prospective screening cohort of high-risk men: effect of TMPRSS2 Met160Val. BJUI. ,vol. 107, pp. 466- 470 ,(2011) , 10.1111/J.1464-410X.2010.09522.X
Robert Vessella, Leroy Hood, Lawrence D. True, Biaoyang Lin, Peter S. Nelson, James T. White, Camari Ferguson, Shunyou Wang, Prostate-localized and Androgen-regulated Expression of the Membrane-bound Serine Protease TMPRSS2 Cancer Research. ,vol. 59, pp. 4180- 4184 ,(1999)
B. E. E. M. Van Den Borne, B. A. C. Dijkmans, C. L. Verweij, H. H. De Rooij, S. Le Cessie, Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells. The Journal of Rheumatology. ,vol. 24, pp. 55- 60 ,(1997)
Stephanie Bertram, Adeline Heurich, Hayley Lavender, Stefanie Gierer, Simon Danisch, Paula Perin, Jared M. Lucas, Peter S. Nelson, Stefan Pöhlmann, Elizabeth J. Soilleux, Influenza and SARS-Coronavirus Activating Proteases TMPRSS2 and HAT Are Expressed at Multiple Sites in Human Respiratory and Gastrointestinal Tracts PLoS ONE. ,vol. 7, pp. e35876- ,(2012) , 10.1371/JOURNAL.PONE.0035876
Paul B. McCray, Lecia Pewe, Christine Wohlford-Lenane, Melissa Hickey, Lori Manzel, Lei Shi, Jason Netland, Hong Peng Jia, Carmen Halabi, Curt D. Sigmund, David K. Meyerholz, Patricia Kirby, Dwight C. Look, Stanley Perlman, Lethal Infection of K18-hACE2 Mice Infected with Severe Acute Respiratory Syndrome Coronavirus Journal of Virology. ,vol. 81, pp. 813- 821 ,(2007) , 10.1128/JVI.02012-06
Kaisa Luostari, Jaana M. Hartikainen, Maria Tengström, Jorma J. Palvimo, Vesa Kataja, Arto Mannermaa, Veli-Matti Kosma, Type II Transmembrane Serine Protease Gene Variants Associate with Breast Cancer PLOS ONE. ,vol. 9, ,(2014) , 10.1371/JOURNAL.PONE.0102519
Jianghua Wang, Yi Cai, Long-jiang Shao, Javed Siddiqui, Nallasivam Palanisamy, Rile Li, Chengxi Ren, Gustavo Ayala, Michael Ittmann, Activation of NF-κB by TMPRSS2/ERG Fusion Isoforms through Toll-Like Receptor-4 Cancer Research. ,vol. 71, pp. 1325- 1333 ,(2011) , 10.1158/0008-5472.CAN-10-2210
Elena V. Fernandez, Kelie M. Reece, Ariel M. Ley, Sarah M. Troutman, Tristan M. Sissung, Douglas K. Price, Cindy H. Chau, William D. Figg, Dual targeting of the androgen receptor and hypoxia-inducible factor 1α pathways synergistically inhibits castration-resistant prostate cancer cells. Molecular Pharmacology. ,vol. 87, pp. 1006- 1012 ,(2015) , 10.1124/MOL.114.097477
S. A. Tomlins, Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer Science. ,vol. 310, pp. 644- 648 ,(2005) , 10.1126/SCIENCE.1117679
Liesel M FitzGerald, Ilir Agalliu, Karynn Johnson, Melinda A Miller, Erika M Kwon, Antonio Hurtado-Coll, Ladan Fazli, Ashish B Rajput, Martin E Gleave, Michael E Cox, Elaine A Ostrander, Janet L Stanford, David G Huntsman, Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer BMC Cancer. ,vol. 8, pp. 230- 230 ,(2008) , 10.1186/1471-2407-8-230